Samodzielny Publiczny Zakład Opieki Zdrowotnej Zespół Szpitali Miejskich
135 notices in the register, 2 open now. 68 contracts awarded, worth €39.7M in all.
Main sectors Medical equipment & pharmaceuticals 55, Software & IT systems 17, Furniture & appliances 12, Office & computing machinery 9, IT services 8, Repair & maintenance services 7
Record
Awards by year
- 2026 15 awards €8.1M
- 2025 30 awards €30.7M
- 2024 1 award €939,085
- €500,000
- €5.0M
- largest, €8.6M
Each dot is one award, placed on its date and sized by its value.
Relations
Who wins with this buyer
- "ROCHE POLSKA" Sp. z o.o.; KOMTUR POLSKA Sp. z o.o.; Janssen-Cilag Polska Sp. z o.o.,; SALUS INTERNATIONAL Sp. z o.o.; "FARMACOL-LOGISTYKA" Sp. z o.o; Amgen Sp. z o.o. 2 contracts €6,203,749
- SIEMENS HEALTHCARE Sp. z o.o. 2 contracts €856,925
- FORIP Sp. z o.o. 2 contracts €439,570
- KOMTUR POLSKA Sp. z o.o.; "FARMACOL-LOGISTYKA" Sp. z o.o; Roche Polska Sp. z o.o.; "ASCLEPIOS" Spółka akcyjna 1 contract €8,614,164
- Abbvie Sp. z o.o.; Urtica Sp. z o. o.; Roche Polska Sp. z o.o.; TAKEDA PHARMA Sp. z o.o.; PFIZER TRADING POLSKA Sp. z o.o.; Astellas Pharma Sp. z o. o. 1 contract €3,370,781
- Urtica Sp. z o. o.; Amgen Sp. z o.o.; AstraZeneca Kft.; Abbvie sp. z o.o.; "FARMACOL-LOGISTYKA" Sp. z o.o; KOMTUR POLSKA Sp. z o.o.; BIALMED Sp. z o.o. 1 contract €2,019,159
- "ROCHE POLSKA" Spółka z ograniczoną odpowiedzialnością; ASCLEPIOS Spółka Akcyjna; JANSSEN-CILAG Polska Spółka z ograniczoną odpowiedzialnością; CSL Behring Sp. z o.o.; Centrala Farmaceutyczna CEFARM SA; Baxter Polska Sp. z o.o.; Medyk-Lek Panek Sp. z o.o. Sp.k.; Urtica Sp. z o. o.; NOBIPHARM Sp. z o 1 contract €1,414,471
- BioMaxima Spółka Akcyjna; BIOMERIEUX POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; ROCHE DIAGNOSTICS Polska SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; CIRRO SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; MEDAN ANDRZEJ HĘDRZAK 1 contract €1,352,249
Shares of the 53 awards this buyer made to a named company.
Practice
How it buys
Publishing rhythm
Publishes most in July and August.
Next likely wave: July 2027.
- Typical contract value
- €771,766
- Median of the last 58 priced notices
Based on 135 notices over the last 24 months.
What to expect from this buyer
Measured in its busiest sector Medical equipment & pharmaceuticals
- Typical final price against the published estimate
- -61%
Medians across the 26 comparable awards this buyer made in this sector over the last 5 years. Each figure uses the awards that publish the dates or values it needs.
Next 90 days
Coming up from this buyer
- tenders announced in advance (last 6 months)
- 0
- contracts due back on the market in the next 90 days
- 2
Scorecard
The buyer in figures
How it runs its calls for tender
- usual bidding window
- 12 days
- of its calls state an estimated value
- 41%
Estimates over its calls for tender of the last 3 years, bidding windows over the last 2. Deadline extensions only where the source updates a notice in place (TED publishes corrections as separate notices, so its buyers show none).
Who wins its contracts
Many suppliers- different companies won its awards
- 50
- of the awards went to the three most frequent winners
- 11%
- of its calls state an estimated value
- 41%
Based on 53 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.2
- of those lots received a single tender
- 75%
- of the awards went to companies based in another country
- 0%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Register